Selective Janus kinase inhibitors come of age

被引：59
|
作者：
O'Shea, John J. [1 ]
Gadina, Massimo [2 ]
机构：
[1] NIAMSD, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA
[2] NIAMSD, Translat Immunol Sect, Bethesda, MD 20892 USA
来源：
NATURE REVIEWS RHEUMATOLOGY | 2019年 / 15卷 / 02期
关键词：
D O I：
10.1038/s41584-018-0155-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Janus kinase (JAK) inhibitors (jakinibs) that target downstream signalling by a large range of cytokines are effective in treating autoimmune and rheumatic diseases. Newer jakinibs that selectively inhibit individual JAKs and a narrower spectrum of cytokines have now been developed, but how do these inhibitors compare with existing drugs?
引用
收藏
页码：74 / 75
页数：3
相关论文
共 50 条
  • [31] Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
    Marti-Carvajal, Arturo J.
    Anand, Vidhu
    Sola, Ivan
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (04):
  • [32] Towards Selective Inhibitors of Janus Kinase 3: Identification of a Novel Structural Variation between Janus Kinases 2 and 3
    Kim, Mi Kyoung
    Chong, Youhoon
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2012, 33 (12): : 4207 - 4210
  • [33] SELECTIVE INHIBITION OF TYROSINE KINASE 2 WITH AN ORAL AGENT, BMS-986165, COMPARED WITH JANUS KINASE INHIBITORS
    Chimalakonda, A.
    Burke, J.
    Cheng, L.
    Strnad, J.
    Catlett, I.
    Patel, A.
    Shen, J.
    Girgis, I.
    Banerjee, S.
    Throup, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1312 - 1312
  • [34] Janus kinase inhibitors in dermatology: A systematic review
    Shreberk-Hassidim, Rony
    Ramot, Yuval
    Zlotogorski, Abraham
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (04) : 745 - +
  • [35] Janus kinase inhibitors role in bone remodeling
    Maruotti, Nicola
    Corrado, Addolorata
    Rotondo, Cinzia
    Cantatore, Francesco Paolo
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (03) : 1915 - 1920
  • [36] Janus kinase inhibitors in autoimmune bullous diseases
    Huang, Dawei
    Zhang, Yuexin
    Kong, Luyang
    Lu, Jiajing
    Shi, Yuling
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [37] Role of Janus Kinase Inhibitors in Therapy of Psoriasis
    Sluczanowska-Glabowska, Sylwia
    Ziegler-Krawczyk, Anna
    Szumilas, Kamila
    Pawlik, Andrzej
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [38] The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis
    Veale, Douglas J.
    McGonagle, Dennis
    McInnes, Iain B.
    Krueger, James G.
    Ritchlin, Christopher T.
    Elewaut, Dirk
    Kanik, Keith S.
    Hendrikx, Thijs
    Berstein, Gabriel
    Hodge, Jennifer
    Telliez, Jean-Baptiste
    RHEUMATOLOGY, 2019, 58 (02) : 197 - 205
  • [39] Janus kinase inhibitors in immunoinflammatory rheumatic diseases
    Hacohob, E. A.
    Nasonov, Evgeny L.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (05) : 605 - 609
  • [40] Identification of selective inhibitors for Janus kinase 1: an integrated drug repurposing strategy for breast cancer
    Sruthy Sathish
    Panneer Devaraju
    Angeline Julius
    Honglae Sohn
    Thirumurthy Madhavan
    Chemical Papers, 2024, 78 : 245 - 262
12345